Skip to content

South Africa’s XDR-TB epidemic is due to transmission rather than evolution of resistant strains

Sarah Auld presenting at CROI 2016. Photo by Theo Smart, hivandhepatitis.com

Empirical TB treatment comes up short again

Alison Grant presenting at CROI 2016. Photo by Liz Highleyman, hivandhepatitis.com

MDR-TB treatment: Six drugs better than five

Xpert MTB/RIF testing has reduced MDR-TB treatment delays in South Africa

One in eight children with confirmed TB have drug-resistant TB in Cape Town

Death during MDR-TB treatment more likely in people with HIV and underweight or most drug-resistant patients

9-month MDR-TB regimen cures 82% in African study

Newest MDR-TB drug prices could fall by up to 95% through generic production

Newest MDR-TB drug prices could fall by up to 95% through generic production

XDR-TB in South Africa is largely spread person-to-person, not by failure of drug treatment

N Sarita Shah presenting at CROI 2015. Photo by Liz Highleyman, hivandhepatitis.com